SCHEMBL21189276

SCHEMBL21189276

COC(=O)NC1CCOc2c(C(=O)Nc3ccc(F)c(Cl)c3)ccc(F)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.46
RAB9A P51151 6/20 0.46
MAPT P10636 5/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
HTT P42858 1/20 0.43
HPGD P15428 1/20 0.43
FADS1 O60427 1/20 0.43
HDAC3 O15379 1/20 0.41
EGFR P00533 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21189275 1.00 NPC1 (0.46) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189195 1.00 NPC1 (0.46) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189527 0.91 MAOB (0.42) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189343 0.91 MAOB (0.42) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189392 0.91 MAOB (0.42) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL19973711 0.91 MEN1 (0.40) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189186 0.91 MAPT (0.44) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL26714606 0.90 NPC1 (0.45) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21189409 0.90 NPC1 (0.43) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL21189433 0.89 APOB (0.40) NPC1RAB9AMAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS NPC1 983/4885RAB9A 1393/4885MAPT 3165/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS NPC1 983/4885RAB9A 1393/4885MAPT 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.